Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Magellan Health, Inc.    MGLN

MAGELLAN HEALTH, INC.

(MGLN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/01/2020 04/02/2020 04/03/2020 04/06/2020 04/07/2020 Date
44.45(c) 43.96(c) 41.73(c) 48.86(c) 48.84(c) Last
202 703 126 176 172 912 150 976 125 756 Volume
-7.61% -1.10% -5.07% +17.09% -0.04% Change
More quotes
Financials (USD)
Sales 2020 7 217 M
EBIT 2020 113 M
Net income 2020 52,9 M
Debt 2020 -
Yield 2020 -
Sales 2021 7 486 M
EBIT 2021 145 M
Net income 2021 88,2 M
Debt 2021 -
Yield 2021 -
P/E ratio 2020 23,0x
P/E ratio 2021 13,7x
Capi. / Sales2020 0,17x
Capi. / Sales2021 0,16x
Capitalization 1 206 M
More Financials
Company
Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its... 
Sector
Managed Healthcare
Calendar
04/30Earnings Release
More about the company
Surperformance© ratings of Magellan Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on MAGELLAN HEALTH, INC.
04/06MAGELLAN HEALTH : Appoints Tim Lacy as Chief Growth Officer
BU
03/20MAGELLAN HEALTH : Expands Telehealth Services to Support Clients during COVID-19..
BU
03/18MAGELLAN HEALTH : Offers Support to Individuals and Customers in Response to the..
BU
03/10MAGELLAN HEALTH INC : Change in Directors or Principal Officers, Financial State..
AQ
03/09MAGELLAN HEALTH : Statement of changes in beneficial ownership of securities
PU
02/28MAGELLAN HEALTH : Management's Discussion and Analysis of Financial Condition an..
AQ
02/28MAGELLAN HEALTH INC : Results of Operations and Financial Condition, Financial S..
AQ
02/28MAGELLAN HEALTH : 4Q Earnings Snapshot
AQ
02/28MAGELLAN HEALTH : Reports 2019 Financial Results and Provides 2020 Guidance
BU
02/18MAGELLAN HEALTH : Announces Fourth Quarter Earnings and 2020 Financial Guidance ..
BU
02/03MAGELLAN HEALTH INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/03MAGELLAN HEALTH : Board of Directors Appoints David Haddock as General Counsel a..
BU
01/07MAGELLAN HEALTH : Complete Care of Arizona Offers Medicare Advantage D-SNP Plan
BU
01/02MAGELLAN HEALTH : Complete Care Of Virginia Offers Medicare Advantage D-SNP Plan
BU
01/02MAGELLAN HEALTH : Opens Toll-Free Crisis Line to Provide Free Consultation Servi..
BU
More news
News in other languages on MAGELLAN HEALTH, INC.
2019WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2019MAGELLAN HEALTH INC : publication des résultats trimestriels
2019MAGELLAN HEALTH INC : Veröffentlichung des Quartalsergebnisses
2019MAGELLAN HEALTH INC : publication des résultats annuels
2019MAGELLAN HEALTH INC : Veröffentlichung des Jahresergebnisses
More news
Chart MAGELLAN HEALTH, INC.
Duration : Period :
Magellan Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MAGELLAN HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 67,00  $
Last Close Price 48,84  $
Spread / Highest target 65,8%
Spread / Average Target 37,2%
Spread / Lowest Target 6,47%
EPS Revisions
Managers
NameTitle
Kenneth J. Fasola Chief Executive Officer & Director
James E. Murray President & Chief Operating Officer
Steve J. Shulman Chairman
Jonathan N. Rubin Chief Financial Officer
Srinivas Koushik Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MAGELLAN HEALTH, INC.-37.58%1 206
UNITEDHEALTH GROUP-15.52%236 555
CIGNA CORPORATION-13.36%65 897
ANTHEM, INC.-25.82%57 245
HUMANA INC.-12.68%41 490
CENTENE CORPORATION-4.33%34 862